InfuSystems Holdings (InfuSystems Holdings) Risk Assessment

View and export this data going back to 1992. Start your Free Trial

What is InfuSystems Holdings Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of InfuSystems Holdings is: Moderate Risk: Sensitive, better choose undervalued stock.

Competitive Comparison of InfuSystems Holdings's Risk Assessment

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

InfuSystems Holdings's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Risk Assessment distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Risk Assessment falls into.

InfuSystems Holdings (AMEX:INFU) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

InfuSystems Holdings Risk Assessment Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

InfuSystems Holdings (InfuSystems Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (AMEX:INFU) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

1TZ:Germany

Address

3851 West Hamlin Road, Rochester Hills, MI, USA, 48309

Website

http://www.infusystem.com

InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.

Executives

Jerod Funke	officer: EVP-Chief HR Officer	3851 WEST HAMLIN RD, ROCHESTER HILLS MI 48309
R. Rimmy Malhotra	director	C/O COMMAND CENTER, INC., 3609 S WADSWORTH BLVD., SUITE 250, LAKEWOOD CO 80235
Gregg Owen Lehman	director	309 HADDON COURT, FRANKLIN X1 37067
Richard Dilorio	officer: Executive Vice President	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Barry G Steele	officer: Executive VP and CFO	500 TOWN CENTER DR., SUITE 200, DEARBORN MI 48126
Carrie Lachance	officer: Executive VP and COO	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Christopher R. Sansone	director	C/O SANSONE ADVISORS, LLC, 151 BODMAN PLACE, SUITE 100, RED BANK NJ 07701
Addam Chupa	officer: Executive VP and CIO	3851 WEST HAMLIN ROAD, ROCHESTER HILLS MI 48309
Kevin Whitman	officer: VP and Corporate Controller	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Thomas Mark Ruiz	officer: VP of Sales and Marketing	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Boyd Ralph F Jr	director
Paul Andrew Gendron	director	740 BANDIT TRAIL, KELLER TX 76248
Jeannine Sheehan	officer: Chief Administrative Officer	31700 RESEARCH PARK DRIVE, MADISON HEIGHTS MI 48071
Blueline Capital Partners Ii, L.p.	director	3480 BUSKIRK AVENUE, SUITE 214, PLEASANT HILL CA 94523
Meridian Tsv Ii, Lp	10 percent owner	405 WEED STREET, NEW CANAAN CT 06840